cephalexin has been researched along with cefpodoxime proxetil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ando, M; Hashimoto, I; Mizuno, A; Morimoto, K; Nakamura, T; Sakai, K; Shinagawa, N; Ueda, T; Watanabe, S; Yura, J | 1 |
| Miyahara, T; Nakayama, I; Onodera, S; Saito, A; Sasaki, N; Shiba, K; Shimada, J; Tamura, M; Tomizawa, M | 2 |
| Allen, SD; Ayers, LW; Barry, AL; Fuchs, PC; Jones, RN; Pfaller, M | 1 |
| Davis, JL; Floerchinger, AM; Papich, MG | 1 |
3 trial(s) available for cephalexin and cefpodoxime proxetil
| Article | Year |
|---|---|
[Clinical evaluation of cefpodoxime proxetil in the treatment of skin and soft tissue infections. A double blind comparison of cefpodoxime proxetil and cefaclor].
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus | 1988 |
[Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia | 1988 |
[Comparative clinical study of CS-807 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Multicenter Studies as Topic; Respiratory Tract Infections | 1988 |
3 other study(ies) available for cephalexin and cefpodoxime proxetil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control.
Topics: Administration, Oral; Cefaclor; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quality Control | 1988 |
Pharmacokinetics, protein binding, and tissue distribution of orally administered cefpodoxime proxetil and cephalexin in dogs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Cefpodoxime Proxetil; Ceftizoxime; Cell Division; Cephalexin; Chromatography, High Pressure Liquid; Cross-Over Studies; Dogs; Intestinal Absorption; Kinetics; Protein Binding | 2010 |